Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Interleukin-12 gene therapy safe in phase I ovarian cancer study

March 8, 2007

New therapeutic strategies for cancer imparted in recent patents

March 8, 2007

AVE-8062 causes necrosis and reduces metabolic activity in ovarian tumors

March 7, 2007

CRT and Fox Chase begin drug discovery collaboration in oncology

March 6, 2007

Protox Therapeutics anticipates 2007 milestones

March 6, 2007

Bevacizumab active in pretreated ovarian cancer

March 6, 2007

Thalidomide Pharmion MAA accepted for review in E.U.

March 5, 2007

Quadramet studied with PSA-TRICOM for hormone-refractory prostate cancer

March 5, 2007

Sunesis files IND for Aurora kinase inhibitor SNS-314

March 5, 2007

Insert and R&D sign agreement on second-generation epothilones

March 5, 2007

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...